Article
Efficacy and safety of sofosbuvir-based triple therapy in hepatitis C genotype 4 infection.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver - 1 Sept 2015
Wehmeyer Malte H, Jordan Sabine, Lüth Stefan, Hartl Johannes, Stoehr Albrecht, Eißing Christiane, Lohse Ansgar W, Petersen Jörg, Buggisch Peter, Schulze Zur Wiesch Julian
Abstract excerpt
BACKGROUND: There are only limited data on sofosbuvir-based treatment regimens in hepatitis C virus (HCV) genotype 4-infected patients. AIMS: To evaluate safety and efficacy of sofosbuvir-based triple-therapy in HCV genotype 4 infection. METHODS: All HCV genotype 4-infected patients who started sofosbuvir-based triple-therapy at our two centres between January and June 2014 were prospectively included (N=24) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.